GR861422B - Nasal pharmaceutical compositions - Google Patents

Nasal pharmaceutical compositions

Info

Publication number
GR861422B
GR861422B GR861422A GR860101422A GR861422B GR 861422 B GR861422 B GR 861422B GR 861422 A GR861422 A GR 861422A GR 860101422 A GR860101422 A GR 860101422A GR 861422 B GR861422 B GR 861422B
Authority
GR
Greece
Prior art keywords
pharmaceutical compositions
nasal pharmaceutical
nasal
compositions
pharmaceutical
Prior art date
Application number
GR861422A
Other languages
English (en)
Inventor
Moise Dr Azria
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of GR861422B publication Critical patent/GR861422B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
GR861422A 1985-06-04 1986-06-02 Nasal pharmaceutical compositions GR861422B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858514090A GB8514090D0 (en) 1985-06-04 1985-06-04 Organic compounds

Publications (1)

Publication Number Publication Date
GR861422B true GR861422B (en) 1986-10-01

Family

ID=10580163

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861422A GR861422B (en) 1985-06-04 1986-06-02 Nasal pharmaceutical compositions

Country Status (21)

Country Link
US (1) US4988512A (el)
JP (1) JPS61282320A (el)
KR (1) KR870000066A (el)
AU (1) AU5824786A (el)
BE (1) BE904863A (el)
CH (1) CH668913A5 (el)
DE (1) DE3617728A1 (el)
DK (1) DK259186A (el)
ES (1) ES8801130A1 (el)
FR (1) FR2582511B1 (el)
GB (3) GB8514090D0 (el)
GR (1) GR861422B (el)
HU (1) HU199300B (el)
IL (1) IL78980A0 (el)
IT (1) IT1214683B (el)
LU (1) LU86457A1 (el)
NL (1) NL8601285A (el)
NZ (1) NZ216393A (el)
PT (1) PT82691B (el)
SE (1) SE8602530L (el)
ZA (1) ZA864164B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
ATE157010T1 (de) * 1991-05-24 1997-09-15 Amylin Pharmaceuticals Inc Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
EP0621775B1 (de) * 1992-01-17 1997-08-06 ALFATEC-PHARMA GmbH Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
EP1061987B1 (en) * 1998-02-13 2006-05-17 Bioniche Life Sciences Inc. Drug delivery system
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6759393B1 (en) 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
AU2005231738A1 (en) * 2004-03-26 2005-10-20 Katz, David F. Mr Bioresponsive polymer system for delivery of microbicides
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US820948A (en) * 1905-01-23 1906-05-22 Edward Baum Device fot treating the nasal passages.
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE1617564A1 (de) * 1966-12-03 1971-04-01 Rudolf Kisro Arzneimitteltraeger
DK135268A (el) * 1973-02-09
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS576403A (en) * 1980-06-12 1982-01-13 Toshiba Corp Recording and reproducing device
GB2090535B (en) * 1981-01-06 1984-09-19 Osman Mohammad Fekry Medical inserts
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules

Also Published As

Publication number Publication date
GB8514090D0 (en) 1985-07-10
PT82691A (en) 1986-07-01
JPS61282320A (ja) 1986-12-12
ZA864164B (en) 1988-01-27
IT1214683B (it) 1990-01-18
SE8602530D0 (sv) 1986-06-04
SE8602530L (sv) 1986-12-05
ES555676A0 (es) 1988-01-01
NZ216393A (en) 1989-08-29
BE904863A (fr) 1986-12-03
FR2582511B1 (fr) 1989-05-26
AU5824786A (en) 1986-12-11
CH668913A5 (de) 1989-02-15
US4988512A (en) 1991-01-29
DE3617728A1 (de) 1986-12-04
DK259186D0 (da) 1986-06-02
DK259186A (da) 1986-12-05
HUT49288A (en) 1989-09-28
KR870000066A (ko) 1987-02-16
IT8648098A0 (it) 1986-06-04
ES8801130A1 (es) 1988-01-01
FR2582511A1 (fr) 1986-12-05
GB2176105A (en) 1986-12-17
GB2213377A (en) 1989-08-16
IL78980A0 (en) 1986-09-30
GB8906584D0 (en) 1989-05-04
HU199300B (en) 1990-02-28
PT82691B (en) 1988-05-03
GB2176105B (en) 1990-03-07
LU86457A1 (fr) 1987-01-13
NL8601285A (nl) 1987-01-02
GB8613284D0 (en) 1986-07-09

Similar Documents

Publication Publication Date Title
GB8626808D0 (en) Pharmaceutical compositions
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8621577D0 (en) Pharmaceutical compositions
GR861422B (en) Nasal pharmaceutical compositions
GB2171600B (en) Pharmaceutical compositions
GB8602625D0 (en) Pharmaceutical compositions
GB8618820D0 (en) Pharmaceutical compositions
GB8607906D0 (en) Pharmaceutical compositions
GB8618249D0 (en) Pharmaceutical compositions
GB8515170D0 (en) Pharmaceutical compositions
GB8602602D0 (en) Pharmaceutical compositions
GB8607848D0 (en) Pharmaceutical compositions
GB8618590D0 (en) Pharmaceutical compositions
GB2182561B (en) Pharmaceutical compositions
GB8610970D0 (en) Pharmaceutical compositions
GB8602601D0 (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
GB8618589D0 (en) Pharmaceutical compositions
GB8523531D0 (en) Pharmaceutical compositions
GB8502887D0 (en) Pharmaceutical compositions
GB8608310D0 (en) Pharmaceutical compositions
GB8608309D0 (en) Pharmaceutical compositions
IE861461L (en) Nasal pharmaceutical composition
GB8506855D0 (en) Pharmaceutical compositions
GB8505298D0 (en) Pharmaceutical compositions